A. Gutiérrez

发表

Reduced Fitness of HIV-1 Resistant to Cxcr4 Antagonists

J. Barretina, E. De Clercq, B. Clotet, 2003, Antiviral therapy.

Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor.

B Clotet, E. De Clercq, B. Clotet, 1999, Molecular pharmacology.

Shift of Clinical Human Immunodeficiency Virus Type 1 Isolates from X4 to R5 and Prevention of Emergence of the Syncytium-Inducing Phenotype by Blockade of CXCR4

E. De Clercq, B. Clotet, J. Blanco, 1999, Journal of Virology.

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication

B. Clotet, J. Blanco, J. Esté, 2002, AIDS.

CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease

J. Barretina, B. Clotet, J. Blanco, 2003, Annals of Hematology.

Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV-1 in vivo.

J. Barretina, B. Clotet, J. Blanco, 2001, AIDS.

Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir).

E. De Clercq, C. Pannecouque, B. Clotet, 1998, Molecular pharmacology.

HIV-1 resistance to the gp41-dependent fusion inhibitor C-34.

B. Clotet, J. Esté, Mercedes Armand-Ugón, 2003, Antiviral research.

Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.

E. De Clercq, B. Clotet, D. Meijer, 1999, AIDS research and human retroviruses.

Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection.

J. Barretina, B. Clotet, J. Blanco, 2000, AIDS research and human retroviruses.

Cell-surface-expressed HIV-1 envelope induces the death of CD4 T cells during GP41-mediated hemifusion-like events.

J. Barretina, B. Clotet, G. Kroemer, 2003, Virology.

Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.

J. Barretina, B. Clotet, J. Blanco, 2002, AIDS research and human retroviruses.

CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro.

J. Barretina, B. Clotet, J. Blanco, 2001, Virology.

Interleukin-7 in Plasma Correlates with CD4 T-Cell Depletion and May Be Associated with Emergence of Syncytium-Inducing Variants in Human Immunodeficiency Virus Type 1-Positive Individuals

J. Barretina, B. Clotet, J. Blanco, 2001, Journal of Virology.

Role of the Human Immunodeficiency Virus Type 1 Envelope Gene in Viral Fitness

P. Kiser, M. Quiñones-Mateu, J. Weber, 2003, Journal of Virology.

Evaluation of the putative role of C‐C chemokines as protective factors of HIV‐1 infection in seronegative hemophiliacs exposed to contaminated hemoderivatives

J. Barretina, B. Clotet, I. Caragol, 2000, Transfusion.

A Bacteriophage Lambda-Based Genetic Screen for Characterization of the Activity and Phenotype of the Human Immunodeficiency Virus Type 1 Protease

B. Clotet, J. Esté, M. Parera, 2000, Antimicrobial Agents and Chemotherapy.

Anti-HIV activity of a novel aminoglycoside-arginine conjugate.

J. Barretina, B. Clotet, J. Blanco, 2002, Antiviral research.

Interleukin-7-Dependent Production of RANTES That Correlates with Human Immunodeficiency Virus Disease Progression

J. Barretina, B. Clotet, J. Esté, 2003, Journal of Virology.

Anti-HIV-1 Activity of Enfuvirtide (T-20) by Inhibition of Bystander Cell Death

J. Barretina, B. Clotet, J. Blanco, 2002, Antiviral therapy.